| Literature DB >> 10903008 |
K J van Erpecum1, N G Venneman, P Portincasa, G P Vanberge-Henegouwen.
Abstract
Various agents may either enhance or impair post-prandial gall-bladder motility, and they are identified in this review. When studying the impact of medication on gall-bladder motility, the effects on interdigestive gall-bladder and intestinal motility should also be taken into account. Patients at high risk of gallstone disease, and patients who are treated chronically with gall-bladder motility inhibiting drugs, may benefit from improved gall-bladder motility using a prokinetic agent. However, there are no long-term studies to prove that such a strategy prevents gallstone formation.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10903008 DOI: 10.1046/j.1365-2036.2000.014s2066.x
Source DB: PubMed Journal: Aliment Pharmacol Ther ISSN: 0269-2813 Impact factor: 8.171